Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;58(3):1479-87.
doi: 10.1128/AAC.01775-13. Epub 2013 Dec 23.

Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis

Affiliations

Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis

Fei Zhao et al. Antimicrob Agents Chemother. 2014.

Abstract

The mechanistic basis for the resistance of Mycobacterium tuberculosis to para-aminosalicylic acid (PAS), an important agent in the treatment of multidrug-resistant tuberculosis, has yet to be fully defined. As a substrate analog of the folate precursor para-aminobenzoic acid, PAS is ultimately bioactivated to hydroxy dihydrofolate, which inhibits dihydrofolate reductase and disrupts the operation of folate-dependent metabolic pathways. As a result, the mutation of dihydrofolate synthase, an enzyme needed for the bioactivation of PAS, causes PAS resistance in M. tuberculosis strain H37Rv. Here, we demonstrate that various missense mutations within the coding sequence of the dihydropteroate (H2Pte) binding pocket of dihydrofolate synthase (FolC) confer PAS resistance in laboratory isolates of M. tuberculosis and Mycobacterium bovis. From a panel of 85 multidrug-resistant M. tuberculosis clinical isolates, 5 were found to harbor mutations in the folC gene within the H2Pte binding pocket, resulting in PAS resistance. While these alterations in the H2Pte binding pocket resulted in reduced dihydrofolate synthase activity, they also abolished the bioactivation of hydroxy dihydropteroate to hydroxy dihydrofolate. Consistent with this model for abolished bioactivation, the introduction of a wild-type copy of folC fully restored PAS susceptibility in folC mutant strains. Confirmation of this novel PAS resistance mechanism will be beneficial for the development of molecular method-based diagnostics for M. tuberculosis clinical isolates and for further defining the mode of action of this important tuberculosis drug.

PubMed Disclaimer

Figures

FIG 1
FIG 1
(A) Ribbon diagram of the N-domain FolC (PDB code 2VOS). The locations of six mutations are shown as thick colored bands (Ile43, Arg49, Ser150, Phe152, Glu153, and Ala183), while the ADP is shown as fine bands. (B) As shown, all the mutated residues either reside in the H2Pte binding loop (α1-α2, residues 36 to 50) or are situated in the α4-α5 loop. The residue Glu40 was not included in the model.
FIG 2
FIG 2
DHFS activity of FolC mutants. The DHFS activities of the purified wild-type FolC and FolC mutants were determined using H2Pte as the substrate. The enzyme activity was assayed as described in Materials and Methods. The data represent the means ± the standard deviations (SD) from three independent experiments.
FIG 3
FIG 3
HPLC-MS analysis of H2PtePAS and H2PtePAS-Glu. (A) H2PtePAS and H2PtePAS-Glu coexisted in the reaction system when not all of the H2PtePAS was consumed by wild-type FolC. (B and C) Wild-type FolC could catalyze ligation of glutamate to H2PtePAS to produce H2PtePAS-Glu in the presence of ATP and Mg2+ (B); however, the FolC mutants could not catalyze this reaction (C). (D) For H2PtePAS, the calculated weight was 330.30 and found weight was ∼329.21 ([M-H]). (E) For H2PtePAS-Glu, the calculated weight was 459.42 and found weight was ∼458.27 ([M-H]). All MS data were acquired in the negative mode.
FIG 4
FIG 4
H2Pte antagonized the effect of PAS on M. tuberculosis H37Ra. The survival of the bacterial cells after 36 h of treatment was determined by the XTT reduction assay as described in Materials and Methods. H37Ra (H2Pte) indicates that bacterial cells were treated with H2Pte at different concentrations (0, 0.1, 0.3, 1, 3, and 10 μg/ml), while H37Ra (H2Pte + PAS) indicates that bacterial cells were treated with both H2Pte (0, 0.1, 0.3, 1, 3, and 10 μg/ml) and PAS (0.1 μg/ml). The data represent the means (bars) ± the SD (error bars) from three independent experiments.
FIG 5
FIG 5
Schematic of FolC-mediated PAS resistance in M. bovis and M. tuberculosis. PAS is incorporated into the folate pathway by FolP1 via competition with PABA, yielding H2PtePAS. (A) Both wild-type FolC and the FolC mutants can catalyze the formation of H2Pte-Glu. (B) In the case of H2PtePAS, the wild-type FolC further incorporates it to produce H2PtePAS-Glu, whereas the FolC mutants do not. FolCwt, wild-type FolC; FolCmut, FolC mutants. The dotted arrow indicates the enzymatic activities of the FolC mutants are greatly reduced compared with that of wild-type FolC, and the fork indicates that this pathway is blocked.

Similar articles

Cited by

References

    1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 282:677–686. 10.1001/jama.282.7.677 - DOI - PubMed
    1. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575–1580. 10.1016/S0140-6736(06)69573-1 - DOI - PubMed
    1. World Health Organization 2012. Global tuberculosis report 2012 World Health Organization, Geneva, Switzerland: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf
    1. Lehmann J. 1946. para-Aminosalicylic acid in the treatment of tuberculosis. Lancet 247:15. 10.1016/S0140-6736(46)91185-3 - DOI - PubMed
    1. Youmans GP, Raleigh GW, Youmans AS. 1947. The tuberculostatic action of para-aminosalicylic acid. J. Bacteriol. 54:409–416 - PMC - PubMed

Publication types

MeSH terms